Thursday, April 16, 2026
35.2
C
Bengaluru
Hot topics
Why Most AI Healthcare Tools Stall at the Pilot Stage
Artificial intelligence (AI) in healthcare consistently demonstrates remarkable technical...
India’s Booming OTC Pain Management Market: Trends, Growth & Consumer Behaviors
India’s Booming Pain Management Market: Trends, Growth & Consumer...
A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act
Sun Pharma’s Odyssey and Organon’s Second Act – And...
Indian Pharma Market Through a Game Theory Lens
A Salil Kallianpur Blog
Explosive value growth, limited volume growth –...
Winning Sales Organization
"Digital in Pharma" Special Issue. Invitation to DigiStorm2017, How to Create a Winning Sales Organization and DigiPharmaX. Avail Early Bird Discount - details inside.
The 500 Billion Dollar Pill: Why Skipping Medicine Is Costing India a Fortune
In the pharmaceutical world, we often focus on the...
A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act
Sun Pharma’s Odyssey and Organon’s Second Act – And...
The Semaglutide Gold Rush: Miracle Cure or Market Mirage?
The Indian Pharmaceutical Market (IPM) has entered a definitive...
The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy
"Those who cannot remember the past are condemned to...
Brecht Vanneste has been appointed as Managing Director of MSD India
He steps into the role with a clear mandate...
The 500 Billion Dollar Pill: Why Skipping Medicine Is Costing India a Fortune
In the pharmaceutical world, we often focus on the...
A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act
Sun Pharma’s Odyssey and Organon’s Second Act – And...
The Semaglutide Gold Rush: Miracle Cure or Market Mirage?
The Indian Pharmaceutical Market (IPM) has entered a definitive...
The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy
"Those who cannot remember the past are condemned to...
Brecht Vanneste has been appointed as Managing Director of MSD India
He steps into the role with a clear mandate...
The 500 Billion Dollar Pill: Why Skipping Medicine Is Costing India a Fortune
In the pharmaceutical world, we often focus on the...
A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act
Sun Pharma’s Odyssey and Organon’s Second Act – And...
The Semaglutide Gold Rush: Miracle Cure or Market Mirage?
The Indian Pharmaceutical Market (IPM) has entered a definitive...
The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy
"Those who cannot remember the past are condemned to...
Brecht Vanneste has been appointed as Managing Director of MSD India
He steps into the role with a clear mandate...
The 500 Billion Dollar Pill: Why Skipping Medicine Is Costing India a Fortune
In the pharmaceutical world, we often focus on the...
A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act
Sun Pharma’s Odyssey and Organon’s Second Act – And...
The Semaglutide Gold Rush: Miracle Cure or Market Mirage?
The Indian Pharmaceutical Market (IPM) has entered a definitive...
The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy
"Those who cannot remember the past are condemned to...
Brecht Vanneste has been appointed as Managing Director of MSD India
He steps into the role with a clear mandate...
Hot topics
Soft Power and the Physician
GST Special Issue carrying an interview with Sunil Attavar - CMD, Group Pharma and President, Karnataka Drugs and Pharmaceuticals Manufacturers Association (KDPMA)
Healthcare Isn’t Working As Well As It Should – A Brief Summary Of The ZS Report 2024
The ZS report discusses how people feel about healthcare...
When Influence Meets Accountability: Why India Wants Wellness Gurus to Show Their Credentials
India’s wellness economy is booming—nutraceuticals, supplements, and alternative therapies...
Prabhir Jha: Digital is not just another technology, it is a mind-set
DigiStorm 2018 was held on 11 September at the...
What pharma marketers get wrong about digital
Marketers often think that everything is new in the digital world. They have simply forgotten the first principle, which is to serve the customers – to have a customer-centric view and not a product-centric one.
The 500 Billion Dollar Pill: Why Skipping Medicine Is Costing India a Fortune
In the pharmaceutical world, we often focus on the...
A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act
Sun Pharma’s Odyssey and Organon’s Second Act – And...
The Semaglutide Gold Rush: Miracle Cure or Market Mirage?
The Indian Pharmaceutical Market (IPM) has entered a definitive...
The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy
"Those who cannot remember the past are condemned to...
Brecht Vanneste has been appointed as Managing Director of MSD India
He steps into the role with a clear mandate...
The 500 Billion Dollar Pill: Why Skipping Medicine Is Costing India a Fortune
In the pharmaceutical world, we often focus on the...
A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act
Sun Pharma’s Odyssey and Organon’s Second Act – And...
The Semaglutide Gold Rush: Miracle Cure or Market Mirage?
The Indian Pharmaceutical Market (IPM) has entered a definitive...
The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy
"Those who cannot remember the past are condemned to...
Brecht Vanneste has been appointed as Managing Director of MSD India
He steps into the role with a clear mandate...
The 500 Billion Dollar Pill: Why Skipping Medicine Is Costing India a Fortune
In the pharmaceutical world, we often focus on the...
A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act
Sun Pharma’s Odyssey and Organon’s Second Act – And...
The Semaglutide Gold Rush: Miracle Cure or Market Mirage?
The Indian Pharmaceutical Market (IPM) has entered a definitive...
The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy
"Those who cannot remember the past are condemned to...
Brecht Vanneste has been appointed as Managing Director of MSD India
He steps into the role with a clear mandate...
The 500 Billion Dollar Pill: Why Skipping Medicine Is Costing India a Fortune
In the pharmaceutical world, we often focus on the...
A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act
Sun Pharma’s Odyssey and Organon’s Second Act – And...
The Semaglutide Gold Rush: Miracle Cure or Market Mirage?
The Indian Pharmaceutical Market (IPM) has entered a definitive...
The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy
"Those who cannot remember the past are condemned to...
Brecht Vanneste has been appointed as Managing Director of MSD India
He steps into the role with a clear mandate...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
The 500 Billion Dollar Pill: Why Skipping Medicine Is Costing India a Fortune
In the pharmaceutical world, we often focus on the...
A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act
Sun Pharma’s Odyssey and Organon’s Second Act – And...
The Semaglutide Gold Rush: Miracle Cure or Market Mirage?
The Indian Pharmaceutical Market (IPM) has entered a definitive...
The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy
"Those who cannot remember the past are condemned to...
Newsletter
Get important news delivered directly to your inbox and stay connected!